Financial results - MEDICANT GASTRODERM S.R.L.

Financial Summary - Medicant Gastroderm S.r.l.
Unique identification code: 36877083
Registration number: J15/1232/2016
Nace: 8622
Sales - Ron
306.299
Net Profit - Ron
265.920
Employee
2
The most important financial indicators for the company Medicant Gastroderm S.r.l. - Unique Identification Number 36877083: sales in 2023 was 306.299 euro, registering a net profit of 265.920 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Medicant Gastroderm S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 0 130.118 170.328 193.714 221.427 260.438 290.160 306.299
Total Income - EUR - - 0 130.118 170.328 193.714 221.427 260.438 290.160 306.299
Total Expenses - EUR - - 0 12.507 18.049 21.751 21.313 19.712 31.329 37.377
Gross Profit/Loss - EUR - - 0 117.611 152.280 171.963 200.113 240.726 258.832 268.922
Net Profit/Loss - EUR - - 0 116.691 150.576 170.025 197.993 238.434 255.988 265.920
Employees - - 0 2 2 2 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 5.9%, from 290.160 euro in the year 2022, to 306.299 euro in 2023. The Net Profit increased by 10.708 euro, from 255.988 euro in 2022, to 265.920 in the last year.

Check the financial reports for the company - Medicant Gastroderm S.r.l.

Rating financiar

Financial Rating -
Medicant Gastroderm S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Medicant Gastroderm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Medicant Gastroderm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Medicant Gastroderm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Medicant Gastroderm S.r.l. - CUI 36877083

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 96 94 1.481 8.741 7.525 5.747 4.478 5.514
Current Assets - - 60 119.106 156.642 30.766 192.544 238.860 253.285 267.118
Inventories - - 0 0 0 0 0 205 0 0
Receivables - - 0 113.707 131.966 7.631 130.949 188.604 233.839 253.924
Cash - - 60 5.399 24.675 23.135 61.595 50.050 19.446 13.194
Shareholders Funds - - 44 116.735 150.619 42 198.035 237.463 256.029 265.961
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 111 2.465 7.504 39.465 2.034 7.143 1.735 6.672
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 267.118 euro in 2023 which includes Inventories of 0 euro, Receivables of 253.924 euro and cash availability of 13.194 euro.
The company's Equity was valued at 265.961 euro, while total Liabilities amounted to 6.672 euro. Equity increased by 10.708 euro, from 256.029 euro in 2022, to 265.961 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Medicant Gastroderm S.r.l.

Comments - Medicant Gastroderm S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.